Semaglutide (Ozempic / Wegovy) and Tirzepatide (Zepbound / Mounjaro) have become familiar names in the world of weight loss. However, conversations in aesthetic medicine are shifting. At our Upper East Side practice, patients aren’t just asking how to lose a substantial amount of weight—they’re asking how to feel more in control of the changes that come with time: increased inflammation in the face and body, high cholesterol levels, or stubborn visceral fat.
Some of these patients are already lean. And increasingly, they’re curious about using GLP-1 weight loss medications like semaglutide and tirzepatide—not at full strength, but at significantly lower doses.
This is where microdosing enters the conversation.
Contents
What Are Semaglutide and Tirzepatide, and Why Are They Used in Aesthetics?
Semaglutide and tirzepatide are GLP-1-based medications originally developed to manage type 2 diabetes. Semaglutide works by mimicking the GLP-1 hormone, which regulates blood sugar, slows gastric emptying, and enhances feelings of fullness. Tirzepatide is a newer medication that combines both GLP-1 and GIP receptor activity—offering a dual mechanism that may lead to even greater metabolic effects.
In the aesthetic setting, these medications are not just about weight loss. Their growing relevance lies in how they influence body composition, inflammation, and insulin sensitivity—factors that affect not only overall wellness but also how the body stores fat and how the skin behaves over time.
Patients on GLP-1s often see reductions in visceral fat and fluid retention, which can impact aesthetic and non-aesthetic changes. These shifts are why semaglutide and tirzepatide are increasingly being explored as adjuncts to aesthetic care.
What Is Microdosing—and Who Is It For?
Microdosing refers to using significantly lower doses of GLP-1 medications than what is typically prescribed for medical weight loss. The goal isn’t dramatic weight reduction, but gentle recalibration—a quieter support for patients who:
- Are already within a healthy weight range but struggle with subtle hormonal weight fluctuations
- Experience puffiness or facial bloating unrelated to diet
- Want to reduce fat while retaining or building muscle mass
- Want to enhance treatments for hormonal challenges like PCOS and autoimmune challenges like lymphadema
- Prefer a metabolically sound approach to aesthetic maintenance as they age
This strategy may also appeal to patients seeking preventative aging support.
How Does Microdosing Compare?
In standard medical weight loss protocols, semaglutide typically begins at 0.25 mg per week, while tirzepatide starts at around 2.5 mg. These doses are designed to curb appetite, slow digestion, and support measurable fat reduction over time.
Microdosing takes a different approach. It involves a cumulative weekly dose that’s roughly one-third to two-thirds of the typical starting dose. At these levels, the goal isn’t intense appetite suppression; it’s metabolic support: more stable blood sugar, reduced fluid retention, and often, less visible puffiness in areas like the face and midsection.
Can This Support Aesthetic Results?
In the right context, yes. Lower-dose GLP-1 weight loss medications may complement a range of aesthetic treatments—not by replacing them, but by supporting what they’re designed to do. For instance:
- Facial sculpting procedures often benefit from reduced systemic inflammation.
- Body contouring results may be easier to maintain with more stable insulin levels.
- It can be used to reach a goal weight for a surgical procedure such as a facelift, submental liposuction, buccal fat removal and others that produce best results for patients at their ideal weight.
It’s not a miracle drug, but it may be one useful lever when thoughtfully prescribed.
Is It the Right Fit for Everyone?
Not always. Even at low doses, GLP-1 medications aren’t appropriate for everyone. Certain medical histories—including a family history of thyroid cancer or specific endocrine conditions—may rule it out entirely.
Dr. Levine carefully reviews each patient’s background, current treatments, and goals before making any recommendation. In aesthetics, more isn’t always better—and sometimes, a conservative, precise adjustment can go further than a high-dose approach.
Strategic Approach to Metabolic Wellness
As always, the key is integration, not isolation. Any use of weight loss medications is considered in the broader context of facial structure, skin quality, hormonal status, and overall wellness.
Interested in Learning More?
If you’re curious about whether microdosing may be right for your aesthetic goals, schedule a private consultation with Dr. Levine. With dual board certification and a commitment to personalized care, she’ll help you understand all the tools available—and how to use them in a way that supports you, not just your reflection.